Overview
WGS market data
Price History
WGS price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$0.73 Diluted earnings per share over the trailing twelve months.
- Beta
- 2.00 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $32.21 – $170.87 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · source Twelve Data /statistics · market cap $2K · P/B 12.20 · P/S 4.47.
Company News
GENEDX HOLDINGS DEADLINE AUGUST 3rd: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against GeneDx Holdings Corp. and Encourages Investors to Contact the FirmGlobenewswire Inc · Jul 27, 2026, 11:15 PM
Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against GeneDx Holdings Corp. and Encourages Investors to Contact the FirmGlobenewswire Inc · Jul 13, 2026, 11:15 PM
HBSS Investigates Claims Against GeneDx Holdings (WGS) in Securities Class Action Suit Following Massive Impairment ChargeGlobenewswire Inc · Jul 8, 2026, 7:15 PM
Guggenheim Maintains Buy on GeneDx Holdings, Raises Price Target to $74Benzinga · Jun 29, 2026, 2:15 PM
Piper Sandler Maintains Overweight on GeneDx Holdings, Raises Price Target to $63Benzinga · Jun 23, 2026, 4:25 PM
GeneDx Holdings (WGS) Faces Securities Class Action After 49% Drop, 94% Write-off Related to Fabric Genomics Acquisition – Hagens BermanGlobenewswire Inc · Jun 22, 2026, 8:15 PM
GeneDx Appointed Mark Gardner To President Effective June 15Benzinga · Jun 16, 2026, 12:45 PM
Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against GeneDx Holdings Corp. and Encourages Investors to Contact the FirmGlobenewswire Inc · Jun 8, 2026, 10:15 PM
Is GeneDx Stock a Buys After a Company Director Purchased Over 350,000 Shares?The Motley Fool · May 21, 2026, 3:15 PM
Bragar Eagel & Squire, P.C. is Investigating GeneDx Holdings Corp. (NASDAQ:WGS) on Behalf of GeneDx Stockholders and Encourages Investors with Losses to Contact the FirmGlobenewswire Inc · May 19, 2026, 11:15 PM